Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, biotech, drugs, healthcare, life sciences, medicines, pharma, pharmaceuticals, top ten

Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …

News
celgene_1_02

NICE greenlights Celgene pancreatic cancer drug as first-line combination treatment

August 4, 2017
Medical Communications, Sales and Marketing Cancer, Celgene, NICE, Pancreatic cancer, drugs, healthcare, life sciences, medicine, pharma, pharmaceuticals

Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …

News
cigarette_smoking

New research reveals genetic mutations in smoking-related cancers

July 27, 2017
Research and Development Cancer, biotech, drugs, health, pharma, pharmaceuticals

Researchers at the Wake Forest School of Medicine in the US have made a big discovery which could help explain …

News

Roche antibody becomes first of its kind authorised for blood cancer

July 26, 2017
Research and Development, Sales and Marketing CDF, Cancer, NICE, drugs, lymphoma, pharma, pharmaceutical Roche

NICE has announced its decision to make Roche’s Gazyvaro available via the Cancer Drugs Fund (CDF) in combination with chemotherapy …

News
shutterstock_141299494

UK underperforming in cancer care compared to Europe, according to ABPI report

July 18, 2017
Research and Development ABPI, Cancer, Pancreatic cancer, biotech, heralthcare, lung cancer, ovarian cancer, pharma, pharmaceutical

According to a new report commissioned by the ABPI, the UK is continuing to fall behind in the diagnosis and …

News
mouse

Investigational drug found to boost treatment efficacy in paediatric brain cancer

July 12, 2017
Research and Development AT/RT, Cancer, DIPG, TAK228, biotech, drugs, pharma, pharmaceutical

Researchers from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University in Baltimore, US, have revealed in a report …

News
shutterstock_159488225

Tumour genome mapping could lead to improved outcomes, research finds

July 5, 2017
Research and Development Cancer, Hi-C

A research team at the Babraham Institute in Cambridge, UK has revealed a new method to detect and monitor large-scale …

News
shutterstock_273326141

American Cancer Society and Melanoma Research Alliance join forces to bring down immunotherapy side-effects

June 29, 2017
Medical Communications, Research and Development American Cancer Society, Cancer, Melanoma Research Alliance, immunotherapy

The American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) have formed a research partnership to reduce the impact …

News
shutterstock_212035546

Investigational antibody boosts chemotherapy’s cancer-killing potential

June 29, 2017
Research and Development CFH, Cancer, oncology, rituximab

A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has …

News

Gold rods used to ‘break cancer’s legs’

June 28, 2017
Research and Development Cancer, Georgia Tech, nanorods

A study emerging from Georgia Tech has found a new way of stopping metastasising cancer’s spread through the body. The …

News
shutterstock_3

New research unlocks the key to slowing cancer metastasis

June 22, 2017
Research and Development Cancer, metastasis

Stemming from a theory she developed as a sophomore at John Hopkins University in Maryland, Hasini Jayatilaka and a team …

News
bicycle_therapeutics

Cambridge start-up secures £40 million to trial innovative cancer drugs

June 16, 2017
Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, Cambridge, Cancer

Bicycle Therapeutics, a biotech start-up based in Cambridge, UK, has just raised £40 million from a range of investors including …

News

BMS’ Opdivo scores eighth approval in Europe for bladder cancer

June 5, 2017
Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, Europe, European Commission, bladder cancer, immunotherapy

Bristol-Myers Squibb has announced that its flagship immunotherapy treatment Opdivo (nivolumab) has secured its eighth approval in Europe as the …

News
aging_-_hand

Latest prostate cancer research could provide boost for J&J

June 5, 2017
Research and Development, Sales and Marketing CRUK, Cancer, Johnson & Johnson, prostate cancer

Research funded by Cancer Research UK has found that abiraterone added to hormone therapy improved survival by over a third …

News
shutterstock_187433765

New targeted therapy promises strong response rate across 17 cancer types

June 5, 2017
Research and Development, Sales and Marketing ASCO, Cancer, Loxo Oncology, oncology

Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026